CVE-2026-15415

medium

Published 2026-07-17 · Modified 2026-07-20

💬 Discuss on Community ✚ Propose mitigation

CVSS v3

5.5

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

CVSS v4 NEW

6.8

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

VIR risk

5.5

Description

AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.

Predictions

Exploit likelihood

55%

Patch ETA

—

Heuristic predictions, AS-IS, for prioritization only.

Mitigations

No mitigations published for this CVE yet.

The vendor-content worker queues fetches as references arrive (check back in a few minutes). Or — if you've already worked around this in production — publish your fix to the community-verified tier.

✚ Propose a mitigation on Community → Mitigations published via the community go through AI scoring + 2 human reviewers + 7-day silent objection window before landing here with source_tier=community-verified.

References

CWEs

CWE-23

Community-verified mitigations for this CVE will appear above when contributors publish them.

Verify integrity in audit chain (admin only). AS-IS.